Meisoindigo tablets are used to treat patients with chronic myeloid leukemia (CML), especially in the population of patients who have failed first-line treatment. As a targeted therapy drug, meisonilogo tablets effectively control the disease and…
Cladribine, originally used as a chemotherapy agent for hematologic malignancies like hairy cell leukemia, has recently shown significant progress in the treatment of multiple sclerosis (MS). FDA Approval of Cladribine Injection for Multiple Sclerosis In…
Romiplostim, sold under brands such as Nplate, is a fusion protein analogue of thrombopoietin, a hormone that regulates platelet production. It is used to treat patients with severe immune thrombocytopenia (ITP), especially those who are…
[January 16, 2025] – Recently, the National Drug Administration (NMPA) formally approved an improved hydroxyurea tablet for marketing, marking an important step in the treatment of blood disorders. The new hydroxyurea tablet adopts a more…
Avapritinib tablets are the medicine used to treat advanced systemic mastocytosis and inert systemic mastocytosis. Avapritinib is also used to treat tumours caused by a specific rare mutation: it is specifically indicated for adults with…
Covalizumab, sold under the brand name Piasky, is a monoclonal antibody used to treat paroxysmal sleep hemoglobinuria. Piasky Crovalimab – A New Hope For The Treatment of Blood Disorders An exciting news comes in the…
As the first biologic agent approved for complement system regulation, eculizumab injection has made a milestone breakthrough in the treatment of refractory diseases such as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS),…
Introduction Glivec Imatinib Mesylate Capsules, sold under the brand name Glivec, is a groundbreaking treatment for Hematology chronic myelogenous leukaemia (CML) and gastrointestinal stromal tumours (GIST). This targeted therapy has provided new hope for patients,…
